FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On February 8, 2005
Table of Contents
Docket # Title
1980N-0208 Biological Products; Bacterial Vaccines and Toxiods
1993F-0357 Safe use of Source of Fast (high energy) Neutrons
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999P-1340 Declared Eternity eau de Parfum Misbranded
2000N-0504 Egg Safety Action Plan
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003D-0466 International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidance for Industry on Studies to Evaluate the Safety of Resid
2003F-0088 Increase the Maximum Permitted Energy Level of X-rays
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
2004D-0361 Guidance for Industry; Prior Notice of Imported Food Contingency Plan for System Outages
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
2004D-0422 Guidance for Industry: Animal Drug Sponsor Fees Under the Animal Drug User Fee Act (ADUFA)
2004D-0460 Guidance for Industry on Listed Drugs, 30-Month Stays, and Approval of ANDAs and 505(b)(2) Applications Under Hatch-Waxman, as Amended by the Medicare Prescription Drug, Improvement, and Modernization
2004D-0462 Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes
2004D-0493 Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
2004G-0381 Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
2004N-0093 Agency Information Collection Activities: Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution , 21 CFR Part 207.
2004N-0416 Beverages: Bottled Water
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
2004N-0498 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Device Tracking
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
2005A-0014 Regarding hip joint metal constrained
2005D-0022 International Conference on Harmonisation; Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
2005D-0030 Guidance for Industry on Clinical Lactation Studies Study Design, Data Analysis, and Recommendations for Labeling
2005N-0016 Agency Information Collection Activities; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs: Study 1
2005N-0031 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification for a New Dietary Ingredient
2005N-0032 Agency Information Collection Activities: Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified Foods and Thermally Processed Lo
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
2005N-0045 Agency Information Collection Activities: Proposed Collection; Comment Request; Electronic Records; Electronic Signatures
1980N-0208 Biological Products; Bacterial Vaccines and Toxiods
EC 24 MILVAX Agency Vol #: 140
EC 25 Mr. Steven Fisher Vol #: 140
EMC 24 S. Hungerford Vol #: 141
EMC 25 Protecting Our Guardians Vol #: 141
EMC 26 B. Hodge Vol #: 141
EMC 27 Protecting Our Guardians Vol #: 141
EMC 28 D. Reed Vol #: 141
EMC 29 K. Veterans Vol #: 141
EMC 30 J. Bostic Vol #: 141
EMC 31 M. Styx Vol #: 141
EMC 32 M. Ammend Vol #: 141
EMC 33 S. Plotkin, MD Vol #: 141
EMC 34 E. Newhouse Vol #: 141
EMC 35 A. Gross Vol #: 141
EMC 36 W. Elwell Vol #: 141
EMC 37 K. Butler Vol #: 141
EMC 38 A. Luna Vol #: 141
EMC 39 R. Yee Vol #: 141
EMC 40 E. Clinton Vol #: 141
EMC 41 J. Hailstone Vol #: 141
EMC 42 D. Buckland Vol #: 141
EMC 43 No signature Vol #: 141
EREG 20 Hubble, John Vol #: 140
EREG 21 Kaufmann, Thomas Vol #: 140
EREG 22 JOHNSON, SCOTT Vol #: 140
EREG 23 Lyles, David Vol #: 140
EREG 24 Koenig, Robin Vol #: 140
1993F-0357 Safe use of Source of Fast (high energy) Neutrons
EMC 107 J. Levitt Vol #: 2
EMC 108 S. Daniel Vol #: 2
EMC 109 M. Carroll Vol #: 2
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 15448 Ideasphere TM Inc. Vol #: 136
LET 15449 Ideasphere TM Inc. Vol #: 136
LET 15450 Ideasphere TM Inc. Vol #: 136
LET 15451 Ideasphere TM Inc. Vol #: 136
LET 15452 Ideasphere TM Inc. Vol #: 136
LET 15453 Ideasphere TM Inc. Vol #: 136
LET 15454 Ideasphere TM Inc. Vol #: 136
LET 15455 Ideasphere TM Inc. Vol #: 136
LET 15456 Ideasphere TM Inc. Vol #: 136
LET 15457 Ideasphere TM Inc. Vol #: 136
LET 15458 Ideasphere Tm Inc. Vol #: 136
LET 15459 Ideasphere TM Inc. Vol #: 136
LET 15460 Ideasphere Tm Inc. Vol #: 136
LET 15461 NOW Foods Vol #: 136
LET 15462 NOW Foods Vol #: 136
LET 15463 Market America, Inc. Vol #: 136
LET 15464 Pharmanex, LLC Vol #: 136
LET 15465 Pharmanex, LLC Vol #: 136
LET 15466 Pharmanex, LLC Vol #: 136
LET 15467 McLind Corporation Vol #: 136
LET 15468 Knature Corporation Vol #: 136
LET 15469 NBTY Inc. Vol #: 136
LET 15470 NBTY Inc. Vol #: 136
LET 15471 NBTY Inc. Vol #: 136
LET 15472 Formulary Herb Products Vol #: 136
LET 15473 DKSH North America, Inc. Vol #: 136
LET 15474 Perrigo Company of south Carolina Vol #: 136
LET 15475 Enzymatic Therapy Vol #: 136
LET 15476 Enzymatic Therapy Vol #: 136
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 579 P. Levy Vol #: 24
2000N-0504 Egg Safety Action Plan
EMC 1897 B and M Wirtz Vol #: 31
EMC 1898 No signature Vol #: 31
EMC 1899 C and H Goldberg Vol #: 31
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EXB 1088 Bayer Corporation Vol #: 480
EXB 1089 Bayer Corporation Vol #: 480
EXB 1090 Bayer Corporation Vol #: 480
EXB 1091 Bayer Corporation Vol #: 480
EXB 1092 Bayer Corporation Vol #: 480
EXB 1093 Bayer Corporation Vol #: 480
EXB 1094 Bayer Corporation Vol #: 480
EXB 1095 Bayer Corporation Vol #: 480
EXB 1096 Bayer Corporation Vol #: 480
EXB 1097 Bayer Corporation Vol #: 480
EXB 1098 Bayer Corporation Vol #: 480
EXB 1099 Bayer Corporation Vol #: 480
EXB 1100 Bayer Corporation Vol #: 480
EXB 1101 Bayer Corporation Vol #: 480
EXB 1102 Bayer Corporation Vol #: 480
EXB 1103 Bayer Corporation Vol #: 480
EXB 1104 Bayer Corporation Vol #: 480
EXB 1105 Bayer Corporation Vol #: 480
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 14078 M. Olson Vol #: 324
EMC 14079 C. Santos Vol #: 324
EMC 14080 T. Santos Vol #: 324
EMC 14081 T. Spurr Vol #: 324
EMC 14082 American Assn of ProLife (AAPLOG) Vol #: 324
EMC 14083 E. Strohl Vol #: 324
EMC 14084 M. Knight Vol #: 324
EMC 14085 S. Cook Vol #: 324
EMC 14086 L. Wilkinson Vol #: 324
EMC 14087 R. Lorentzen Vol #: 324
EMC 14088 S. Hoffert Vol #: 324
EMC 14089 A. Faust Vol #: 324
EMC 14090 R. Lorentzen Vol #: 324
EMC 14091 M. Langan Vol #: 324
EMC 14092 E. Good Vol #: 324
EMC 14093 J. White Vol #: 324
EMC 14094 L. Kippin Vol #: 324
EMC 14095 N. Shanfeld Vol #: 324
EMC 14096 O. Bretches Vol #: 324
EMC 14097 T. Pang Vol #: 324
EMC 14098 A. Nickelson Vol #: 324
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
EMC 1255 V. Brannen, MS, LAPC Vol #: 5
EMC 1256 M. Elmore Vol #: 5
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
EMC 203 M. Hollinrake Vol #: 4
EMC 204 T. Bader Vol #: 4
EMC 205 C. Guerrero Vol #: 4
EMC 206 K. Philadephia Vol #: 4
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 426 Calorie Control Council Vol #: 7
EMC 427 Mission Possible International Vol #: 7
EMC 428 Mission Possible International Vol #: 7
2003D-0466 International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidance for Industry on Studies to Evaluate the Safety of Resid
GDL 2 Guidance Vol #: 1
NAD 2 FDA Vol #: 1
2003F-0088 Increase the Maximum Permitted Energy Level of X-rays
EC 1 Ms. Sarah Reinhardt Vol #: 3
EC 2 Mr. Joshua Broberg Vol #: 3
EC 3 Mr. Daniel Shively Vol #: 3
EC 4 Mrs. Isobel Reinhardt Vol #: 3
EC 5 Ms. Lisa Reinhardt Vol #: 3
EC 6 Mr. Ray Reinhardt Vol #: 3
EC 7 Ms. Babette Bolton Vol #: 3
EMC 117 No signature Vol #: 2
EMC 118 C. Stone, R.D. Vol #: 2
EMC 119 J. Masanz Vol #: 2
EMC 120 B. Szalwinski Vol #: 2
EMC 121 A. Geisler Vol #: 2
EMC 122 V. Gonzalez Vol #: 2
EMC 123 K. Collins Vol #: 2
EMC 124 L. Marshall Vol #: 2
EMC 125 M. Reed Vol #: 2
EMC 126 R. Pullen Vol #: 2
EMC 127 W. McClatchey Vol #: 2
EMC 128 W. Stroud Vol #: 2
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 523 K. Makimaa Vol #: 9
EMC 524 J. Lavin Vol #: 9
EMC 525 A. Christensen Vol #: 9
EMC 526 K. Hansell Vol #: 9
EMC 527 M. Yamada Vol #: 9
EMC 528 U. Foggetti Vol #: 9
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
BKG 3 Background Vol #: 4
NM 2 FDA Vol #: 4
2004D-0361 Guidance for Industry; Prior Notice of Imported Food Contingency Plan for System Outages
EC 4 OLBIS Ltd., Moscow Vol #: 1
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
EC 462 Miss. Carmen Olmedo Vol #: 17
EC 463 Miss. Laurie Leibel Vol #: 17
EC 464 Mr. Tom Rigby Vol #: 17
EC 465 Ms. Anna Reggiani Vol #: 17
EC 466 planet Earth Vol #: 17
EC 467 Mr. Bret walburg Vol #: 17
EC 468 The George Washington University Economics Dep't Vol #: 17
EC 469 Ms. Katherine Kemp Vol #: 17
EC 470 Ms. Sara Pic Vol #: 17
EC 471 Ms. eve mitchell Vol #: 17
EC 472 Dr. Monica Bolton Vol #: 17
EC 473 United Fresh Fruit and Vegetable Association Vol #: 17
EC 474 Mr. David Ingalsbe Vol #: 17
EC 475 Pioneer Hi-Bred International, Inc. Vol #: 17
EC 476 Law Offices of Steven D. Wiener Vol #: 17
EC 477 Mr. Thomas OConnor Vol #: 17
EC 478 Dr. Frances Lamberts Vol #: 17
EC 479 Mr. Keith Abeles Vol #: 17
EC 480 National Campaign for Sustainable Agriculture Vol #: 17
EC 481 None Vol #: 17
EC 482 None Vol #: 17
EC 483 Mrs. Tere Daane Vol #: 17
EC 484 Ms. Vicki Gay Vol #: 17
EC 485 Dr. Michael Phillips Vol #: 17
EC 486 Miss. Anna Galle Vol #: 17
EC 487 Mr. Greg Blomstrom Vol #: 17
EC 488 HEB Grocery Co LP Vol #: 17
EC 489 ILSI Health and Environmental Sciences Institute Vol #: 17
EC 490 Consumers Union Vol #: 17
EC 491 Ms. Justine Holgan Vol #: 17
EC 492 Ms. Patricia O'Leary Vol #: 17
EC 493 independent citizen Vol #: 17
EC 494 Grupo de Estudios Ambientales Vol #: 17
EC 495 University of California Santa Cruz Vol #: 17
EC 496 Ms. Debby Bolen RN Vol #: 17
EC 497 Mrs. Isobel Reinhardt Vol #: 17
EC 498 The Center for Food Safety Vol #: 17
EC 499 Ms. Lisa Reinhardt Vol #: 17
EC 500 Mr. Ray Reinhardt Vol #: 17
EC 501 Ms. Raquel Carrillo Vol #: 17
EC 502 Ms. Babette Bolton Vol #: 17
EC 503 Miss. Lisa Marselle Vol #: 17
EC 504 Mr. Trey Carland Vol #: 17
2004D-0422 Guidance for Industry: Animal Drug Sponsor Fees Under the Animal Drug User Fee Act (ADUFA)
BKG 1 Background Material Vol #: 1
GDL 2 Guidance Vol #: 1
NAD 2 FDA Vol #: 1
2004D-0460 Guidance for Industry on Listed Drugs, 30-Month Stays, and Approval of ANDAs and 505(b)(2) Applications Under Hatch-Waxman, as Amended by the Medicare Prescription Drug, Improvement, and Modernization
EC 3 Mr. Peter Ritz Vol #: 1
2004D-0462 Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes
EC 1 Sangart, Inc. Vol #: 1
EC 2 Sangart, Inc. Vol #: 1
EC 3 Alliance Pharmaceutical Corp. Vol #: 1
EC 4 AABB Vol #: 1
EC 5
Attachment
Health Research Associates Vol #: 1
EC 6 America's Blood Centers Vol #: 1
2004D-0493 Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
EC 1 GlaxoSmithKline Vol #: 1
EC 2 Pfizer Vol #: 1
2004G-0381 Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
EC 5 Food Marketing Institute Vol #: 1
EC 6 International Fresh-cut Produce Association Vol #: 1
EC 7 Federal Express Corporation Vol #: 1
EC 8 Grocery Manufacturers of America Vol #: 1
2004N-0093 Agency Information Collection Activities: Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution , 21 CFR Part 207.
NAL 1 FDA Vol #: 1
SS 1 Supporting Statement Vol #: 1
2004N-0416 Beverages: Bottled Water
EMC 2 International Bottled Water Assn (IBWA) Vol #: 2
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
EMC 526 G. West Vol #: 8
EMC 527 D. McMahon, ND Vol #: 8
EMC 528 S. Seay Vol #: 8
EMC 529 D. Stittgen Vol #: 8
EMC 530 M. Brenard Vol #: 8
EMC 531 D. Beamer Vol #: 8
EMC 532 C. Squier Vol #: 8
EMC 533 J. Zayachek Vol #: 8
EMC 534 M. McDaniel Vol #: 8
EMC 535 K. Eisenhart Vol #: 8
EMC 536 S. Knutson Vol #: 8
EMC 537 E. Leach Vol #: 8
EMC 538 R. Fucetola, JD Vol #: 8
EMC 539 V. Fisher Vol #: 8
EMC 540 E. Craig Vol #: 8
EMC 541 E. Munson Vol #: 8
EMC 542 B. Bielema Vol #: 8
EMC 543 J. Barton Vol #: 8
EMC 544 K. Krueger Vol #: 8
EMC 545 M. Rogers Vol #: 8
EMC 546 L. Hammer Vol #: 8
EMC 547 L and I Berman Vol #: 8
EMC 548 N. Thomas Vol #: 8
EMC 549 D. Locke Vol #: 8
EMC 550 C. Shafer Vol #: 8
EMC 551 G. Leinbach Vol #: 8
EMC 552 P. Rudnick Vol #: 8
EMC 553 S. Marcus Vol #: 8
EMC 554 D. Shelton Vol #: 8
EMC 555 K. Miller Vol #: 8
EMC 556 H. Harman Vol #: 8
EMC 557 M. Soye Vol #: 8
EMC 558 F. Leppert Vol #: 8
EMC 559 B. Thedford Vol #: 8
EMC 560 P. Harding Vol #: 8
EMC 561 C. Snedden Vol #: 8
EMC 562 L. Solomon Vol #: 8
EMC 563 M. Hand Vol #: 8
EMC 564 P. Beavin Vol #: 8
EMC 565 R. Straker Vol #: 8
EMC 566 B. BAch Vol #: 8
EMC 567 C. Coleman Vol #: 8
EMC 568 S. David Vol #: 8
EMC 569 S. Davis Vol #: 8
EMC 570 N. Fox Vol #: 8
EMC 571 H. Elias Vol #: 8
EMC 572 C. Mordecai Vol #: 8
EMC 573 M. Steiskal Vol #: 8
EMC 574 F. Sacco Vol #: 8
EMC 575 H. Ellas Vol #: 8
EMC 576 J. Lund Vol #: 8
EMC 577 D. Brady Vol #: 8
EMC 578 M. Tartaglia Vol #: 8
EMC 579 T. Mosegaard Vol #: 8
EMC 580 F. Heard Vol #: 8
EMC 581 J. Erlandsen Vol #: 8
EMC 582 E. Bolger Vol #: 8
EMC 583 E. Piotrowicz Vol #: 8
EMC 584 T. Small Vol #: 8
EMC 585 M. Korosy Vol #: 8
EMC 586 R. Mankinen Vol #: 8
EMC 587 M. Dzindzeleta Vol #: 8
EMC 588 M. Betz Vol #: 8
EMC 589 B. Labrecque Vol #: 8
EMC 590 M. Sting Vol #: 8
EMC 591 T. McConnell Vol #: 8
EMC 592 D. Simcox Vol #: 8
EMC 593 V. Gasorski Vol #: 8
EMC 594 D. Pfalmer Vol #: 8
EMC 595 D. Young Vol #: 8
EMC 596 A. Theisen Vol #: 8
EMC 597 W and V Ralston Vol #: 8
EMC 598 S. Stirling Vol #: 8
EMC 599 D. Pergamit Vol #: 8
EMC 600 D. Monroe Vol #: 8
EMC 601 D. Monroe Vol #: 8
EMC 602 No signature Vol #: 8
EMC 603 M. and C Roda Vol #: 8
EMC 604 B. Christy Vol #: 8
EMC 605 C. Krueger Vol #: 8
EMC 606 S. Murtha Vol #: 8
EMC 607 R and M HArding Vol #: 8
EMC 608 D. Lyon Vol #: 8
EMC 609 D. Palm Vol #: 8
EMC 610 Y. Griffith Vol #: 8
EMC 611 R. Ketvirtis Vol #: 8
EMC 612 A. Gore Vol #: 8
EMC 613 S. Foss Vol #: 8
EMC 614 S. Knisley Vol #: 8
EMC 615 D. Short Vol #: 8
EMC 616 K. Cornelder Vol #: 8
EMC 617 J. Sehl Vol #: 8
EMC 618 R. Gaskill, Jr. Vol #: 8
EMC 619 T. McKey Vol #: 8
EMC 620 J. Hayes Vol #: 8
EMC 621 M. Souza Vol #: 8
EMC 622 J. Anderson Vol #: 8
EMC 623 R. Clifford Vol #: 8
EMC 624 P. Tunison Vol #: 8
EMC 625 R. Weiss Vol #: 8
EMC 626 C. Brandi Vol #: 8
EMC 627 L. Henderson Vol #: 8
EMC 628 R. Mardocco Vol #: 8
EMC 629 J. Hanson Vol #: 8
EMC 630 W. Rose Vol #: 8
EMC 631 R. Goodrich Vol #: 8
EMC 632 D. Paden Vol #: 8
EMC 633 T. Bowling Vol #: 8
EMC 634 K. Jacoby Vol #: 8
EMC 635 S. Kramer Vol #: 8
EMC 636 L. Hitzeman Vol #: 8
EMC 637 L. Lacy Vol #: 8
EMC 638 D. Halvorson Vol #: 8
EMC 639 S. Mannelli Vol #: 8
EMC 640 C. Sotmary Vol #: 8
EMC 641 J. Lounsberry Vol #: 8
EMC 642 L. Veralli Vol #: 8
EMC 643 S. Keehn Vol #: 8
EMC 644 J. HAas Vol #: 8
EMC 645 J. Rouse Vol #: 8
EMC 646 B. Simmons Vol #: 8
EMC 647 M. Frisby Vol #: 8
EMC 648 D. Slifer Vol #: 8
EMC 649 M and T Piecynski Vol #: 8
EMC 650 J. Stewart Vol #: 8
EMC 651 J. Young Vol #: 8
EMC 652 C. Burch Vol #: 8
EMC 653 A. Fuhrman Vol #: 8
EMC 654 S. Novack Vol #: 8
EMC 655 J. Kelly Vol #: 8
EMC 656 L. Hughes Vol #: 8
EMC 657 R. Chapple Vol #: 8
EMC 658 M. Lynk Vol #: 8
EMC 659 G. Draper Vol #: 8
EMC 660 S. Moorlag Vol #: 8
EMC 661 P and C Friederich Vol #: 8
EMC 662 A. Lovejoy Vol #: 8
EMC 663 L. Whitworth-Reed Vol #: 8
EMC 664 M. Garrette Vol #: 8
EMC 665 L. Semeraro Vol #: 8
EMC 666 J. Pillsbury Vol #: 8
EMC 667 O. Fisher Vol #: 8
EMC 668 C. Smith Vol #: 8
EMC 669 H. Leibacher Vol #: 8
EMC 670 J. Landrith Vol #: 8
EMC 671 S. Veit Vol #: 8
EMC 672 J. Foshee Vol #: 8
EMC 673 D. Adams Vol #: 8
EMC 674 T. Aman Vol #: 8
EMC 675 K. Quelland Vol #: 8
EMC 676 C. Moury Vol #: 8
EMC 677 C. Kirby Vol #: 8
EMC 678 A. Briddell Vol #: 8
EMC 679 D. Humphrey Vol #: 8
EMC 680 M. Chipman Vol #: 8
EMC 681 L. Lambert Vol #: 8
EMC 682 T. Owens Vol #: 8
EMC 683 V. Burke Vol #: 8
EMC 684 K. Hammad Vol #: 8
EMC 685 R. DiBernardo Vol #: 8
EMC 686 S. Steinberg Vol #: 8
EMC 687 W. LaMasters Vol #: 8
EMC 688 L. Williams Vol #: 8
EMC 689 M. Hart Vol #: 8
EMC 690 B. Ellerbeck Vol #: 8
EMC 691 C. Turner Vol #: 8
EMC 692 M. Shulman Vol #: 8
EMC 693 R. Holsworth Vol #: 8
EMC 694 K. Huff Vol #: 8
EMC 695 D. Verri Vol #: 8
EMC 696 J. Tschirhart Vol #: 8
EMC 697 R. Lewis Vol #: 8
EMC 698 D. Smith Vol #: 8
EMC 699 L. Dragas Vol #: 8
EMC 700 D. Simpson Vol #: 8
EMC 701 G. McCormick Vol #: 8
EMC 702 A. Riddick Vol #: 8
EMC 703 E. Hamidi Vol #: 8
EMC 704 G. Lawler Vol #: 8
EMC 705 W. Cheek Vol #: 8
EMC 706 R. Tyrrell Vol #: 8
EMC 707 A. Storrie Vol #: 8
EMC 708 A. Donovan Vol #: 8
EMC 709 C. Hart Vol #: 8
EMC 710 K. Beers Vol #: 8
EMC 711 E. Friedman Vol #: 8
EMC 712 N. Neff Vol #: 8
EMC 713 M. Marrs Vol #: 8
EMC 714 B. Schoolfield Vol #: 8
EMC 715 A. Young Vol #: 8
EMC 716 K. Berger Vol #: 8
EMC 717 D. Bonenberger Vol #: 8
EMC 718 J. Dalhaus Vol #: 8
EMC 719 L. D'Antonio Vol #: 8
EMC 720 E. North Vol #: 8
EMC 721 S. Fischer Vol #: 8
EMC 722 S. Wiemeier Vol #: 8
EMC 723 T. Becker Vol #: 8
EMC 724 P. Plattner Vol #: 8
EMC 725 K. Chamberlain Vol #: 8
EMC 726 D. Distefano Vol #: 8
EMC 727 B. Pakalniskis Vol #: 8
EMC 728 D. Pakalniskis Vol #: 8
EMC 729 I. Tavens Vol #: 8
EMC 730 J. Loomis Vol #: 8
EMC 731 R. Gibb Vol #: 8
EMC 732 C. Dugan Vol #: 8
EMC 733 S. Sigmond Vol #: 8
EMC 734 T. Bridges Vol #: 8
EMC 735 L. Sellers Vol #: 8
EMC 736 R. Scherffius Vol #: 8
EMC 737 J. Herzog Vol #: 8
EMC 738 R. Mumm, CD, MS Vol #: 8
EMC 739 B. Athman Vol #: 8
EMC 740 L. Sollberger Vol #: 8
EMC 741 K. Barnette Vol #: 8
EMC 742 J. Buchberger Vol #: 8
EMC 743 B. Surface Vol #: 8
EMC 744 D. Varney Vol #: 8
EMC 745 D. Stroud Vol #: 8
EMC 746 A. Morningstar Vol #: 8
EMC 747 D. Collins Vol #: 8
EMC 748 A. Pevear Vol #: 8
EMC 749 W. Anderson Vol #: 8
EMC 750 R. Howard Vol #: 8
EMC 751 J. Smith Vol #: 8
EMC 752 F. Martin Vol #: 8
EMC 753 W. Johnson Vol #: 8
EMC 754 J. Dykstra Vol #: 8
EMC 755 W. and M Messier Vol #: 8
EMC 756 L. Tuck Vol #: 8
EMC 757 D. Franz Vol #: 8
EMC 758 O. Williams Vol #: 8
EMC 759 B. Tonsberg Vol #: 8
EMC 760 C. Smith Vol #: 8
EMC 761 E. White Vol #: 8
EMC 762 J. Grubb Vol #: 8
EMC 763 L. Hooton Vol #: 8
EMC 764 B. Hudspith Vol #: 8
EMC 765 S. Joyce Vol #: 8
EMC 766 G. Maisenhelder Vol #: 8
EMC 767 N. Risley Vol #: 8
EMC 768 G. Rober Vol #: 8
EMC 769 C. Wellman Vol #: 8
EMC 770 A. Livingston Vol #: 8
EMC 771 C. Hardesty Vol #: 8
EMC 772 R and B Vigars Vol #: 8
EMC 773 C and C Golden Vol #: 8
EMC 774 T Gasior Vol #: 8
EMC 775 L. Kraft Vol #: 8
EMC 776 C. Kasaoka Vol #: 8
EMC 777 A. Eberlein Vol #: 8
EMC 778 W. Barrett Vol #: 8
EMC 779 V and L Pera Vol #: 8
EMC 780 S. Brown Vol #: 8
EMC 781 L. Toh Vol #: 8
EMC 782 D. Fischer Vol #: 8
EMC 783 J. Pasque Vol #: 8
EMC 784 R. Peterson Vol #: 8
EMC 785 E. Hollis Vol #: 8
EMC 786 M. Leo Vol #: 8
EMC 787 G. Fischer Vol #: 8
EMC 788 F. Cochrane Vol #: 8
EMC 789 L. Biasci Vol #: 8
EMC 790 V. Bramner Vol #: 8
EMC 791 J. Ekdahl Vol #: 8
EMC 792 J. Trowbridge Vol #: 8
EMC 793 W. Burton Vol #: 8
EMC 794 J. Benjamin Vol #: 8
EMC 795 B. Merrill Vol #: 8
EMC 796 H. Adams Vol #: 8
EMC 797 M. Kindscher Vol #: 8
EMC 798 A. Campbell Vol #: 8
EMC 799 B G Vol #: 8
EMC 800 A. Bonte Vol #: 8
EMC 801 S. Macy Vol #: 9
EMC 802 E. Smith Vol #: 9
EMC 803 D. Splater Vol #: 9
EMC 804 T. Madison Vol #: 8
EMC 805 F. Patterson Vol #: 9
EMC 806 J. Turner Vol #: 9
EMC 807 G. Liming Vol #: 9
EMC 808 L. Stinnett Vol #: 9
EMC 809 M. House Vol #: 9
EMC 810 D. Paulson Vol #: 9
EMC 811 K. Blackett Vol #: 9
EMC 812 E. Barone Vol #: 9
EMC 813 V. Alcoset Vol #: 9
EMC 814 C. Williams Vol #: 9
EMC 815 D. Larsen Vol #: 9
EMC 816 J. Repar Vol #: 9
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
EC 15 Mrs. Linda Piel Vol #: 1
EC 16 Mrs. Gayle Rogalski Vol #: 1
EC 17 Mrs. Vickie Taylor Vol #: 1
EC 18 Ms. Nancy Shearman Vol #: 1
EC 19 Ms. Barbara Schultz Vol #: 1
EC 20 Mrs. Alana Plock Vol #: 1
EC 21 MY SELF Vol #: 1
EC 22 Mr. Jeffrey Plakos Vol #: 1
EC 23 Mr. Frode Jensen Vol #: 1
EC 24 Mr. Phil Gilbert Vol #: 1
EC 25 Ms. Charlotte Weiland Vol #: 1
EC 26 ProDynamic Health Vol #: 1
EC 27 Ms. Libby Rupp Vol #: 1
EC 28 Dr. Alice Forsyth Vol #: 1
EC 29 Mr. Brian Hirsch Vol #: 1
EC 30 Mr. John Andrews Vol #: 1
EC 31 Mrs. Diane Jimenez-Stinson Vol #: 1
EC 32 Ms. donna powell Vol #: 1
EC 33 Mrs. Tina Moore Vol #: 1
EC 34 Dr. Richard Seedman, DVM Vol #: 1
EC 35 Dr. gigi gaulin Vol #: 1
EC 36 Dr. Paula Broadfoot Vol #: 1
EC 37 Ms. Susan Michetti Vol #: 1
2004N-0498 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Device Tracking
EC 1 EID Ltd. Vol #: 1
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
EMC 17 Westeon A. Price Foundation Vol #: 5
2005A-0014 Regarding hip joint metal constrained
ACK 2 HFA-305 to Bill G. Pierson # 907177 Vol #: 1
AP 2 Bill G. Pierson # 907177 Vol #: 1
2005D-0022 International Conference on Harmonisation; Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2005D-0030 Guidance for Industry on Clinical Lactation Studies Study Design, Data Analysis, and Recommendations for Labeling
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2005N-0016 Agency Information Collection Activities; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs: Study 1
N 1 FDA Vol #: 1
2005N-0031 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification for a New Dietary Ingredient
N 1 FDA Vol #: 1
2005N-0032 Agency Information Collection Activities: Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified Foods and Thermally Processed Lo
N 1 FDA Vol #: 1
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
NH 1 FDA Vol #: 1
2005N-0045 Agency Information Collection Activities: Proposed Collection; Comment Request; Electronic Records; Electronic Signatures
N 1 FDA Vol #: 1
N 2 Number not used Vol #: 1

Page created on February 9, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management